azacitidine has been researched along with Experimental Mammary Neoplasms in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (38.89) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 6 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balko, JM; Gonzalez-Ericsson, PI; Li, H; Liu, F; Luo, N; Manning, HC; Nickels, ML; Nixon, MJ; Opalenik, SR; Sanchez, V; Sanders, ME; Tantawy, MN; Zahnow, CA | 1 |
| Blosser, RL; Diaz, LA; Kim, K; Kinzler, KW; Li, Z; Liu, Q; Papadopoulos, N; Skora, AD; Tam, AJ; Vogelstein, B; Zhou, S | 1 |
| Baek, A; Bear, HD; Damle, SR; Graham, LJ; Manjili, MH; Payne, KK; Terracina, KP | 1 |
| Ali, IY; Gupta, C; Gupta, J; Tikoo, K | 1 |
| Fernandez, SV; Giulianelli, S; Goin, M; Lanari, C; Russo, J; Wargon, V | 1 |
| Bast, RC; Feng, Y; Huan, J; Jia, L; Jin, H; Lu, Z; Yao, M; Yu, Y; Zhao, N; Zou, CF | 1 |
| Colizzi, F; Coral, S; Covre, A; Dalla Santa, S; Fonsatti, E; Fratta, E; Maio, M; Nicolay, HJ; Parisi, G; Rizzo, A; Sigalotti, L | 1 |
| Kriukova, IN; Lushnikova, AA; Makhov, PB | 1 |
| Bocci, G; Ebos, JM; Emmenegger, U; Francia, G; Green, SK; Kerbel, RS; Man, S; Shaked, Y; Weinerman, A | 1 |
| Di, GH; Fan, J; Hou, YF; Lei, W; Li, DQ; Lu, JS; Shao, ZM; Shen, ZZ; Wu, FY; Wu, J; Yin, WJ | 1 |
| Donaghue, TP; Frost, P; Kerbel, RS; Liteplo, RG | 1 |
| Carlow, DA; Elliott, BE; Frost, P; Kerbel, RS; Liteplo, R | 1 |
| Momparler, LF; Momparler, RL; Rivard, GE; Samson, J | 1 |
| Brissette, L; Deeley, RG; Elliott, BE; Holden, JJ; Marshall, J; Mudrik, K; Vekemans, M; Xu, W | 1 |
| Frost, P; Hunt, B; Kerbel, RS; Man, S; Pathak, S | 1 |
| Arnold, M; Bosman, P; Carlow, DA; Elliott, BE; Hampton, N; Ivimey, L | 1 |
| Bufalari, A; Cavaliere, A; Vitali, R | 1 |
| Alvarez, E; Elliott, BE; Houghton, AN; Kerbel, RS | 1 |
1 review(s) available for azacitidine and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Possible epigenetic mechanisms of tumor progression: induction of high-frequency heritable but phenotypically unstable changes in the tumorigenic and metastatic properties of tumor cell populations by 5-azacytidine treatment.
Topics: Animals; Azacitidine; DNA; Ethyl Methanesulfonate; Humans; Mammary Neoplasms, Experimental; Methylation; Methylnitronitrosoguanidine; Models, Genetic; Mutation; Neoplasm Metastasis; Neoplasms; Neoplastic Stem Cells; Phenotype; Stem Cells | 1984 |
17 other study(ies) available for azacitidine and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
DNA methyltransferase inhibition upregulates MHC-I to potentiate cytotoxic T lymphocyte responses in breast cancer.
Topics: Animals; Antineoplastic Agents; Azacitidine; Breast Neoplasms; Cell Line, Tumor; DNA (Cytosine-5-)-Methyltransferase 1; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Genes, MHC Class I; Humans; Mammary Neoplasms, Experimental; Mice; Promoter Regions, Genetic; T-Lymphocytes, Cytotoxic | 2018 |
Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells.
Topics: Animals; Antibodies, Monoclonal; Azacitidine; Benzamides; Cell Line, Tumor; Colorectal Neoplasms; Combined Modality Therapy; CTLA-4 Antigen; Epigenesis, Genetic; Female; Histone Deacetylase Inhibitors; Humans; Immunotherapy; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Myeloid Cells; Neoplasm Metastasis; Phosphoinositide-3 Kinase Inhibitors; Programmed Cell Death 1 Receptor; Pyridines | 2014 |
DNA methyltransferase inhibition increases efficacy of adoptive cellular immunotherapy of murine breast cancer.
Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Breast Neoplasms; Cell Line, Tumor; Decitabine; DNA Modification Methylases; Enzyme Inhibitors; Female; Humans; Immunotherapy, Adoptive; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice; Mice, Inbred BALB C; T-Lymphocytes | 2016 |
5-Azacytidine prevents cisplatin induced nephrotoxicity and potentiates anticancer activity of cisplatin by involving inhibition of metallothionein, pAKT and DNMT1 expression in chemical induced cancer rats.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Azacitidine; Blood Urea Nitrogen; Blotting, Western; Breast Neoplasms; Cell Nucleus; Cisplatin; Colonic Neoplasms; Creatinine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; Drug Synergism; Drug Therapy, Combination; Female; Histones; Kidney Diseases; Male; Mammary Neoplasms, Experimental; Metallothionein; Neoplasms, Experimental; p38 Mitogen-Activated Protein Kinases; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley | 2009 |
Hypermethylation of the progesterone receptor A in constitutive antiprogestin-resistant mouse mammary carcinomas.
Topics: Animals; Apoptosis; Azacitidine; Cell Culture Techniques; Cell Line, Tumor; Coculture Techniques; Decitabine; DNA Methylation; DNA Modification Methylases; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Hormone Antagonists; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mifepristone; Mitosis; Neoplasm Transplantation; Promoter Regions, Genetic; Receptors, Glucocorticoid; Receptors, Progesterone; Transplantation, Heterologous; Tumor Burden | 2011 |
Re-expression of ARHI (DIRAS3) induces autophagy in breast cancer cells and enhances the inhibitory effect of paclitaxel.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Azacitidine; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Decitabine; Gene Expression Regulation, Neoplastic; Green Fluorescent Proteins; Humans; Hydroxamic Acids; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; rho GTP-Binding Proteins; RNA Interference; Transplantation, Heterologous | 2011 |
Epigenetic remodelling of gene expression profiles of neoplastic and normal tissues: immunotherapeutic implications.
Topics: Animals; Antigens, Neoplasm; Azacitidine; Cell Line, Tumor; Cell Transformation, Neoplastic; Decitabine; DNA Methylation; Epigenesis, Genetic; Epigenomics; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Immunotherapy; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Promoter Regions, Genetic; Receptors, G-Protein-Coupled; Signal Transduction | 2012 |
[Effect of 5-azacytidine on expression of DNA sequences homologous to ENV gene of murine mammary tumor virus in normal human lymphocytes].
Topics: Animals; Antigens, Viral, Tumor; Azacitidine; Cells, Cultured; Female; Gene Expression; Genes, env; Humans; Interferons; Male; Mammary Neoplasms, Experimental; Mammary Tumor Virus, Mouse; Mice; Polymerase Chain Reaction; Sequence Homology, Nucleic Acid; T-Lymphocytes; Tumor Cells, Cultured | 2002 |
Down-regulation of DNA mismatch repair proteins in human and murine tumor spheroids: implications for multicellular resistance to alkylating agents.
Topics: Adaptor Proteins, Signal Transducing; Adenosine Triphosphatases; Animals; Antineoplastic Agents, Alkylating; Azacitidine; Base Pair Mismatch; Blotting, Western; Carrier Proteins; Cell Line, Tumor; Cisplatin; DNA Methylation; DNA Repair; DNA Repair Enzymes; DNA-Binding Proteins; Drug Resistance, Neoplasm; Humans; Hydroxamic Acids; Mammary Neoplasms, Experimental; Mice; Mismatch Repair Endonuclease PMS2; MutL Protein Homolog 1; Nuclear Proteins; Promoter Regions, Genetic; Spheroids, Cellular; Tumor Cells, Cultured | 2005 |
[Expression of ER alpha in chemically induced MDA-MB-435 cells and its responsiveness to endocrine].
Topics: Animals; Azacitidine; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Decitabine; DNA Modification Methylases; Enzyme Inhibitors; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Ovariectomy; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Trefoil Factor-1; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays | 2006 |
Selection of strongly immunogenic "tum-" variants from tumors at high frequency using 5-azacytidine.
Topics: 5-Methylcytosine; Animals; Antigens, Neoplasm; Azacitidine; Cell Transformation, Neoplastic; Cytosine; DNA; Ethyl Methanesulfonate; Mammary Neoplasms, Experimental; Mast-Cell Sarcoma; Methylnitronitrosoguanidine; Mice; Mice, Inbred A; Mice, Inbred DBA; Mice, Nude; Mutagens; Neoplasm Transplantation; Phenotype | 1984 |
Cell cycle effects and cellular pharmacology of 5-aza-2'-deoxycytidine.
Topics: Animals; Azacitidine; Cell Cycle; Cell Line; Cell Survival; Decitabine; DNA Replication; Female; Mammary Neoplasms, Experimental; Mice; Mutation; Thioguanine | 1984 |
Outgrowth of stable class I major histocompatibility complex-expressing subsets from immunogenic variants of a murine mammary carcinoma: association with a differentially staining region on chromosome 9.
Topics: Adenocarcinoma; Animals; Antigens, Neoplasm; Azacitidine; Biomarkers, Tumor; Chromosome Mapping; Clone Cells; Female; Genetic Markers; Graft Rejection; H-2 Antigens; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred CBA; Mice, Nude; Neoplasm Transplantation; Phenotype | 1991 |
Selection of metastatic variants with identifiable karyotypic changes from a nonmetastatic murine tumor after treatment with 2'-deoxy-5-azacytidine or hydroxyurea: implications for the mechanisms of tumor progression.
Topics: Animals; Azacitidine; Cell Division; Clone Cells; Decitabine; DNA; Female; Hydroxyurea; Karyotyping; Mammary Neoplasms, Experimental; Mathematics; Mice; Mice, Inbred CBA; Neoplasm Metastasis; Phenotype | 1987 |
In situ augmentation of class I major histocompatibility antigen expression on immunogenic variants of a spontaneous murine mammary carcinoma.
Topics: Adenocarcinoma; Animals; Azacitidine; Decitabine; Female; Graft Rejection; Histocompatibility Antigens; Histocompatibility Antigens Class II; Mammary Neoplasms, Experimental; Methylnitronitrosoguanidine; Mice; Mice, Inbred C3H; Mice, Inbred CBA; Neoplasm Transplantation | 1987 |
5-Azacytidine carcinogenesis in BALB/c mice.
Topics: Animals; Azacitidine; Carcinogens; Female; Lung Neoplasms; Lymphoma; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Skin Neoplasms | 1987 |
Heritable high frequency modulation of antigen expression in neoplastic cells exposed to 5-aza-2'-deoxycytidine or hydroxyurea: analysis and implications.
Topics: Animals; Antigens, Neoplasm; Azacitidine; Decitabine; DNA, Neoplasm; Histocompatibility Antigens; Humans; Hydroxyurea; Mammary Neoplasms, Experimental; Melanoma, Experimental; Methylation; Mice; Tumor Cells, Cultured | 1988 |